Insufficient scRNA-seq data for expression of MAFA at single-cell level.
Insufficient scRNA-seq data for expression of MAFA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 96% | 151.77 | 316 / 328 | 49% | 3.37 | 87 / 178 |
muscle | 100% | 1589.33 | 803 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 90% | 42.55 | 1205 / 1335 | 0% | 0 | 0 / 0 |
thymus | 75% | 26.84 | 489 / 653 | 14% | 0.67 | 86 / 605 |
kidney | 69% | 18.69 | 61 / 89 | 8% | 0.33 | 74 / 901 |
heart | 73% | 23.54 | 631 / 861 | 0% | 0 | 0 / 0 |
esophagus | 40% | 10.79 | 576 / 1445 | 21% | 0.65 | 38 / 183 |
stomach | 42% | 9.89 | 151 / 359 | 4% | 0.09 | 12 / 286 |
lung | 34% | 8.15 | 196 / 578 | 12% | 0.58 | 137 / 1155 |
peripheral blood | 43% | 9.80 | 403 / 929 | 0% | 0 | 0 / 0 |
skin | 42% | 13.01 | 760 / 1809 | 1% | 0.03 | 6 / 472 |
spleen | 43% | 9.61 | 103 / 241 | 0% | 0 | 0 / 0 |
brain | 35% | 16.92 | 922 / 2642 | 3% | 0.36 | 23 / 705 |
adrenal gland | 23% | 7.05 | 60 / 258 | 12% | 2.57 | 28 / 230 |
intestine | 29% | 5.59 | 283 / 966 | 4% | 0.16 | 21 / 527 |
prostate | 31% | 10.12 | 75 / 245 | 2% | 0.04 | 11 / 502 |
uterus | 6% | 0.88 | 10 / 170 | 26% | 1.15 | 119 / 459 |
liver | 7% | 3.58 | 15 / 226 | 20% | 2.42 | 83 / 406 |
adipose | 24% | 4.84 | 292 / 1204 | 0% | 0 | 0 / 0 |
ovary | 3% | 0.41 | 5 / 180 | 19% | 1.10 | 81 / 430 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.46 | 8 / 45 |
breast | 9% | 2.02 | 41 / 459 | 5% | 0.13 | 59 / 1118 |
bladder | 5% | 0.67 | 1 / 21 | 5% | 0.13 | 24 / 504 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030073 | Biological process | insulin secretion |
GO_0009749 | Biological process | response to glucose |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | MAFA |
Protein name | V-maf musculoaponeurotic fibrosarcoma oncogene homolog A Transcription factor MafA (Pancreatic beta-cell-specific transcriptional activator) (RIPE3b1 factor) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog A) |
Synonyms | |
Description | FUNCTION: Transcription factor that activates insulin gene expression . Acts synergistically with NEUROD1/BETA2 and PDX1 . Binds the insulin enhancer C1/RIPE3b element . Binds to consensus TRE-type MARE 5'-TGCTGACTCAGCA-3' DNA sequence . . |
Accessions | ENST00000333480.3 D4Q8H3 Q8NHW3 |